• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

Infographic: Long-Term Data on Switching to Biosimilar Infliximab

Article

Two recent studies have provided long-term data on the safety and efficacy of switching patients from Remicade to its biosimilars.

Two recent studies have provided long-term data on the safety and efficacy of switching patients from Remicade to its biosimilars.

infographic detailing long-term data on switching from Remicade to biosimilar infliximab
Related Videos
Lakesha Farmer from Cencora
Here are the top 5 biosimilar articles for the week of May 20, 2024.
Here are the top 5 biosimilar articles for the week of May 13, 2024.
Jeffrey Casberg, RPh, MS.
The Top 5 Center for Biosimilars Articles for the Week of May 6, 2024.
Related Content
© 2024 MJH Life Sciences

All rights reserved.